These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32366290)

  • 21. Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.
    Xia J; Feng Y; Li M; Yu X; Zhang Y; Duan J; Zhan Q
    BMC Infect Dis; 2020 Aug; 20(1):637. PubMed ID: 32854630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).
    Ma X; Liang M; Ding M; Liu W; Ma H; Zhou X; Ren H
    Med Sci Monit; 2020 Aug; 26():e925364. PubMed ID: 32759887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Umbilical cord blood-derived mesenchymal stem cells in treating a critically ill COVID-19 patient.
    Tao J; Nie Y; Wu H; Cheng L; Qiu Y; Fu J; Jiang X
    J Infect Dev Ctries; 2020 Oct; 14(10):1138-1145. PubMed ID: 33175709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19: immunopathology and its implications for therapy.
    Cao X
    Nat Rev Immunol; 2020 May; 20(5):269-270. PubMed ID: 32273594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
    Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
    Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
    Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.
    Moll G; Drzeniek N; Kamhieh-Milz J; Geissler S; Volk HD; Reinke P
    Front Immunol; 2020; 11():1091. PubMed ID: 32574263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
    Golchin A; Seyedjafari E; Ardeshirylajimi A
    Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.
    Tzotzos SJ; Fischer B; Fischer H; Zeitlinger M
    Crit Care; 2020 Aug; 24(1):516. PubMed ID: 32825837
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T Cells Tested in Patients With COVID-19 ARDS.
    Abbasi J
    JAMA; 2020 Aug; 324(6):539. PubMed ID: 32780125
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.
    Wang YY; Li XZ; Wang LB
    Stem Cell Res Ther; 2013 May; 4(3):45. PubMed ID: 23673003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in mesenchymal stem cell-based therapy for acute lung injury.
    Liang J; Dai W; Xue S; Wu F; Cui E; Pan R
    Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care.
    Ronco C; Navalesi P; Vincent JL
    Lancet Respir Med; 2020 Mar; 8(3):240-241. PubMed ID: 32035509
    [No Abstract]   [Full Text] [Related]  

  • 37. Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations.
    Pehote G; Vij N
    Cells; 2020 Aug; 9(9):. PubMed ID: 32847034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prone Position of Patients With COVID-19 and Acute Respiratory Distress Syndrome.
    Flynn Makic MB
    J Perianesth Nurs; 2020 Aug; 35(4):437-438. PubMed ID: 32741521
    [No Abstract]   [Full Text] [Related]  

  • 39. Endobronchial ultrasound is feasible and safe to diagnose pulmonary embolism in non-transportable SARS-CoV-2 ARDS patients requiring extracorporeal lung support.
    Decavele M; Trosini-Désert V; Boussouar S; Duceau B; Dres M; Demoule A
    Crit Care; 2020 Sep; 24(1):564. PubMed ID: 32958034
    [No Abstract]   [Full Text] [Related]  

  • 40. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.